Related Experiment Video
Updated: May 11, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
The relationship between vitamin D and PTH levels and cardiovascular risk in the elderly hypertensives
Sena Memnune Ulu1, Alper Ulaslı, Fatima Yaman
1Department of Internal Medicine and Nephrology .
Insights
Hypertension in older adults is linked to vitamin D deficiency and high parathyroid hormone levels, both increasing cardiovascular risk. Early treatment of hypertension and vitamin D deficiency is recommended for this age group.
Area of Science:
- Endocrinology
- Cardiology
- Geriatrics
Background:
- Vitamin D deficiency and elevated parathyroid hormone (PTH) are increasingly recognized as potential contributors to cardiovascular risk.
- Hypertension is a major risk factor for cardiovascular disease, particularly in the elderly population.
Purpose of the Study:
- To investigate the relationship between vitamin D, parathyroid hormone (PTH), and cardiovascular risk (CVR) in hypertensive patients aged 65 and over.
- To compare CVR, blood pressure stages, and vitamin D/PTH levels between hypertensive patients and normotensive controls.
Main Methods:
- Study included 84 hypertensive patients and 68 normotensive controls.
- Levels of 25-(OH) vitamin D and PTH were measured.
- Cardiovascular risk degrees and blood pressure stages were assessed and compared with vitamin D and PTH levels.
Main Results:
- Patients with vitamin D deficiency (VDD) had significantly higher systolic and diastolic blood pressure (BP) than those without VDD (p<0.001).
- Patients with hyperparathyroidism exhibited significantly higher systolic and diastolic BP compared to those without (p=0.012, p=0.036).
- Cardiovascular risk (CVR) showed a significant inverse correlation with vitamin D levels (r=-0.752, p<0.001) but not with hyperparathyroidism (r=0.210, p=0.055).
Conclusions:
- Hypertension in older adults is associated with vitamin D deficiency (VDD).
- The stage of hypertension contributes to vitamin D insufficiency, hyperparathyroidism, and elevated cardiovascular risk.
- Clinicians should consider aggressive management of hypertension and VDD in patients over 65.
Introduction And Objective:
In this study, we aimed to investigate the relationship between vitamin D, parathyroid hormone (PTH) and cardiovascular risk (CVR) in hypertensive patients aged 65 years and over.
Patients And Methods:
This study was performed with 84 hypertensive patients and 68 normotensive control group in Afyon Kocatepe University Faculty of Medicine Hospital. The determined cardiovascular risk degrees and the stages of blood pressure were compared with the levels of 25-(OH) vitamin D and PTH.
Results:
Mean systolic and diastolic blood pressure (BP) levels of the patients with vitamin D deficiency (VDD) were significantly higher than those without VDD (p<0.001 for both). Mean systolic and diastolic BP levels of the patients with hyperparathyroidism were significantly higher than those without hyperparathyroidism (p=0.012, p=0.036, respectively). CVR was reversely correlated with vitamin D but the correlation with hyperparathyroidism did not reach statistically significant level (r=-0.752, p<0.001) and (r=0.210, p=0.055), respectively.
Conclusion:
These results indicate that the presence of hypertension is associated with VDD, as well as the stage of hypertension contributes to insufficiency, hyperparathyroidism and increased CVR. Clinicians should be aware and perhaps more aggressive for the treatment of HT and VDD in patients over 65 years of age.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Peripheral Artery Disease III: Interprofessional Care
Hypertension and Regulation of Blood Pressure